Is FDA Above the Law?
This article was originally published in RPM Report
Executive Summary
The Food and Drug Administration is increasingly replacing rulemaking with guidance. The outcome of two legal cases indicates how that trend may be undercutting the administration's message of transparency.
You may also be interested in...
Medical Device Regulation: Change is in the Air
As the FDA revamps the medical device approval process, significant overhauls are expected for both the PMA and 510(k) pathways. Medtech Insight is presenting a series of articles focusing on the effect these changes will have to the industry, starting with this first installment focused on potential changes to premarket approvals.
Medical Device Regulation: Change is in the Air
As the FDA revamps the medical device approval process, significant overhauls are expected for both the PMA and 510(k) pathways. Medtech Insight is presenting a series of articles focusing on the effect these changes will have to the industry, starting with this first installment focused on potential changes to premarket approvals.
Avandia and the Commercial Impact of FDA's Credibility Gap
GlaxoSmithKline's diabetes drug Avandia survived a perilous FDA advisory committee review. The real question is whether the industry can survive the damage to FDA's credibility.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: